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Abstract
With the severe acute respiratory syndrome epidemic of 2003 and renewed attention on avian influenza viral pandemics,
new surveillance systems are needed for the earlier detection of emerging infectious diseases. We applied a ‘‘next-
generation’’ parallel sequencing platform for viral detection in nasopharyngeal and fecal samples collected during seasonal
influenza virus (Flu) infections and norovirus outbreaks from 2005 to 2007 in Osaka, Japan. Random RT-PCR was performed
to amplify RNA extracted from 0.1–0.25 ml of nasopharyngeal aspirates (N=3) and fecal specimens (N=5), and more than
10 mg of cDNA was synthesized. Unbiased high-throughput sequencing of these 8 samples yielded 15,298–32,335 (average
24,738) reads in a single 7.5 h run. In nasopharyngeal samples, although whole genome analysis was not available because
the majority (.90%) of reads were host genome–derived, 20–460 Flu-reads were detected, which was sufficient for subtype
identification. In fecal samples, bacteria and host cells were removed by centrifugation, resulting in gain of 484–15,260 reads
of norovirus sequence (78–98% of the whole genome was covered), except for one specimen that was under-detectable by
RT-PCR. These results suggest that our unbiased high-throughput sequencing approach is useful for directly detecting
pathogenic viruses without advance genetic information. Although its cost and technological availability make it unlikely
that this system will very soon be the diagnostic standard worldwide, this system could be useful for the earlier discovery of
novel emerging viruses and bioterrorism, which are difficult to detect with conventional procedures.
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Introduction
Acute respiratory infections and diarrhea are the leading causes of
childhood morbidity and mortality worldwide, each resulting in an
estimated nearly 2 million deaths annually [1,2]. The diagnosis of
respiratory and gastric/digestive infections is complex, due to the
wide range of potential pathogens that can present with the same
clinical symptoms [3].Inaddition to themany knowncauses ofthese
infections, it has been suggested that unrecognized infectious agents,
includingviruses,remainto bediscovered [4]. Itisestimated that, on
average, up to 40% of diarrhea cases are of unknown etiology [4]
and that the majority (69%) of upper respiratory infections are
caused by viruses, including undiscovered ones [1].
Nucleic acid amplification tests (NATs) are increasingly being
used for the diagnosis of viral infections. The most familiar formats
use DNA or RNA target amplification methods, such as reverse
transcription (RT) PCR, and have sensitivities that are greater
than culture- or antigen-based procedures [3]. Loop-mediated
isothermal amplification is more convenient and sensitive than
PCR in amplifying DNA targets, and can be combined
successfully with an RT step for RNA respiratory viruses.
However, the wide variety of potential pathogens that elicit
similar clinical symptoms and diseases makes the application of
individual DNA- or RNA-based diagnostic assays both complex
and expensive. Even multiplex PCRs are limited to 20–30
candidate pathogens, and may be confounded if viral evolution
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4219results in mutations at the primer binding sites [2]. DNA
microarrays offer unprecedented opportunities for multiplexing;
however, they are not widely implemented in clinical microbiology
laboratories because of problems with sensitivity, throughput, and
validation [2]. In addition, these microarrays are unavailable for
unknown and/or unexpected microbes, as they require genetic
information for each tested pathogen.
Newly-developed ‘‘next-generation’’ sequencing technologies,
such as 454 (Roche), Solexa (Illumina), and SOLiD (ABI), allow
researchers, in an unbiased manner, to obtain millions of sequences
in a single round of operation [5]. Among these sequencing
technologies, 454 currently offers by far the longest read length,
,250 bp on the Genome Sequencer (GS) FLX platform [6].
Sequencing error levels are low (,1%) and arise primarily from
homopolymer runs [7], but tend to be resolved in cases where there
is sufficient coverage depth to allow the assembly of overlapping
reads [8]. Many studies have used 454 pyrosequencing for the
analysis of PCR amplicons, bacterial artificial chromosomes,
genomic, mitochondrial, plastid DNA, and expression profiling
[9,10,11,12,13,14]. 454 is also a powerful tool for pathogen
discovery [15], and was used with the GS platform to identify a
new arenavirus transmitted through solid-organ transplantation
[16] and a new polyomavirus in samples of Merkel cell skin
carcinoma [17]. The 454 sequencing technique was also used to
implicate Israeli acute paralysis virus as a significant marker for
colony collapse disorder in honey bees [18]. Another group
reported the whole genome analysis of Gallid herpesvirus, and
showed that .99.0% coverage was obtained by assembling the raw
sequence data to an overall average coverage depth of 13 [19].
We previously demonstrated the direct detection of a bacterial
pathogen from a patient sample using 454 high-throughput DNA
sequencing[20].Herewereportthe design anddiagnosticvalidation
of an unbiased high-throughput sequencing method for the direct
diagnosis of viral infections in clinical specimens. Patient samples
were obtained during seasonal influenza virus (Flu) infections and
norovirus outbreaks from 2005 to 2007 in Osaka, Japan. cDNAs, as
templates for the GS FLX platform, were prepared by random RT-
PCR using RNAs extracted from clinical samples. High-throughput
sequencing yielded 15,298–32,335 sequences, of which 7–15,260
represented the targeted viral sequences. Furthermore, sequences of
two recently identified human viruses, WU polyomavirus (WUV)
and human coronavirus (HCoV) HKU1, were detected from the
nasal and fecal samples, respectively.
Results
Random RT-PCR Amplification by the Transplex WTA Kit
Total RNA isolated from either nasopharyngeal aspirates or
fecal samples (0.1–0.2 ml) was under-measurable with an ND-
1000 spectrophotometer (NanoDrop Technologies). Therefore, we
performed quasi-random RT-PCR amplification using a whole
transcriptome amplification (WTA) kit, according to the manu-
facturer’s protocol with modifications, i.e. 70 cycles of PCR [21].
After random RT-PCR amplification, 10–13 mg of cDNA were
obtained from the nasal and fecal samples (Figure 1A).
Semi-quantitative PCR was performed using 10-fold serial
dilutions of the amplified cDNA as templates. Flu-specific PCR
detected positive signals in all three nasopharyngeal aspirates
(Figure 1B),and norovirus-specificprimer setsdetectedthe norovirus
genome in four fecal samples, excluding #N1 sample (Figure 1C).
The endpoint of detection in sample #N3 without 70 cycles of PCR
amplification was E+03 (Figure 1C, left panel), whereas that with
PCR amplification was E+06 (Figure 1C, right panel), suggesting
that the viral cDNA was amplified almost 1,000 times by the 70
cyclesofPCR.TogetherwiththeresultsthattotalRNA/cDNAwere
also amplified from several nanograms (data not shown) to ,10 mg
byrandomRT-PCR,theseresultsindicatethatviralgenomescanbe
amplified similar to other DNAs with the WTA kit. Because almost
all of the amplified cDNA were within the 200–1,000 bp range
(Figure 1A), the PCR products were directly used as templates for
emulsion PCR in the GS FLX pyrosequencing.
Pyrosequencing Using the GS FLX Platform
The GS FLX system produces several million bases in one 7.5 h
run [20]. The PicoTiterPlate device, physical divided into 16
regions, was used in this study, with 8 samples being loaded into 2
regions each. A single run yielded 15,298–32,335 (average 24,738)
reads. Data analysis was basically performed according to the
protocol we previously reported [20]. However, since the template
cDNA for the high-throughput sequencing was prepared with
random RT-PCR, an extra step was added to remove tag
sequences in order to use the sequence data for BLASTN search
analyses. Figure 2 shows the fraction of organisms (from which the
sequences in the database were derived) that showed the best hits
for the query sequences (E-value,10
25). To identify viral species
including subtype, higher matches (E-value,10
240) for the
sequence reads were selected (Table 1).
Nasal Samples
The Flu sequence was detected from all three samples in
21,858–30,958 (average 25,978) reads, as shown in Table 2. A
partial genome was covered in these samples, and the cover rate
ranged 8.1–58.3% (Table 2). One major reason for the partial
coverage might be the large amount of host-derived sequences
(90.0–94.6%; Table 2 and Figure 2), which were due to our direct
RNA isolation from nasopharyngeal aspirates without the
elimination of host or bacterial cells. However, 20–460 reads
were Flu-derived, which was sufficient for subtype identification
(H1N1 in sample #F2 and H3N2 in samples #F1 and #F3) from
these sequences (Table S1).
In addition to the Flu sequence, a WUV-derived sequence was
detected in one specimen (#F3) (Figure 3A). Because the detected
sequences were located in a single gene (VP1), the presence of a
second gene (VP2) was confirmed with PCR (Figure 3B). WUV
and another novel human polyomavirus KI were cloned from
respiratory tract specimens in 2007 [20,22,23,24]. Although their
etiological role in childhood respiratory disease has been proposed
[23,24], inconsistent epidemiological results have been reported
[25]. In this study, the WUV-positive patient was a kindergarten
student who was co-infected with Flu, consistent with the report by
Norje et al. [25]. Partial sequences of the human endogenous
retrovirus HCML-ARV were detected in sample #F1 (Table 1),
although the pathogenesis of this virus is unknown.
The number of bacterial sequences read was 572 (#F1), 230
(#F2), and 272 (#F3), and the relative ratio to the total number of
reads was 1.9%, 1.2%, and 1.2%, respectively (Table 2). The most
abundantly detected bacterial sequences were Streptococcus pneumo-
niae, Moraxella bovis, Moraxella bovoculi, Haemophilus influenzae, and
Escherichia coli (data not shown), which were present as major
bacteria in the respiratory tract of children.
Fecal Samples
To remove bacteria and human cells present in the feces,
15,000 rpm centrifugation was performed and the supernatants
were used for RNA isolation. The norovirus sequence was
detected from all five samples in 15,298–32,335 (average 23,994)
reads, as summarized in Table 3. In contrast with influenza virus,
almost the whole genome was covered in #N2 (7,302 reads) and
Metagenomic Pathogen Detection
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and 258.7, respectively (Table 3). More than 75% of the genome
was covered in #N4 (484 reads) and #N5 (611 reads) samples
(Table 3). A BLAST search of each sequence strongly indicated
that these four patients were infected with a similar genotype,
GII.4 (Table S2), consistent with previous diagnostic results [26].
In contrast, only 7 reads were detected in sample #N1 (Table 3),
which was under-detectable with single round of PCR (Figure 1C),
suggesting that the diagnostic method using high-throughput
pyrosequencing is more sensitive than conventional PCR analysis.
One-step real time RT-PCR (qRT-PCR) was also performed on
the extracted RNA. The estimated copy number of norovirus in
each fecal sample is shown in Figure 1C. The copy number of
norovirus in sample #N1 with qRT-PCR was 3E+03, whereas
those of other samples ranged from 1E+06 to 5E+07. The relative
copy numbers of norovirus in samples #N1 to #N3, which were
isolated in 2006 (October to December), were almost consistent
with the semi-quantitative PCR results, although the sensitivity of
the semi-quantitative PCR was 10-fold lower than that of qRT-
PCR (Figure 1C). By contrast, the real-time RT-PCR and semi-
quantitative PCR were ,1,000-fold different in samples #N4 and
#N5 (Figure 1C), which were isolated in May 2005 and January
2006, respectively. In these samples, RNA isolation for 454
pyrosequencing was performed in February 2007, whereas RNA
for qRT-PCR was isolated just after sample collection. Thus, the
above inconsistencies might be due to the storage periods of the
samples (at 4uC).
HCoV-HKU1, which was recently identified as the fifth human
coronavirus [27], was detected in one specimen (#N4). A total of
14 reads from 18,014 reads matched to the HCoV-HKU1 virus,
with four regions being detected (Table 4). Epidemiological studies
have reported that HCoV-HKU1 was found in the nasopharyn-
geal aspirates of 10/418 (2.4%) studied patients with community-
Figure 2. Pyrosequencing using the GS FLX system. Amplified
cDNA was used as a template for GS FLX analysis. A 70675 PicoTiterPlate
device (gasket for 16 regions) was divided into 2 regions each for 8
samples.Obtaineddatawerethensubjectedtoadataanalysispipeline, as
described in the Methods section. Comparison of the organisms from
which the best matches for the sequences was shown.
doi:10.1371/journal.pone.0004219.g002
Figure 1. Random RT-PCR amplification of cDNA from clinical specimens and quantitative RT-PCR with virus-specific primers. The
samples were nasopharyngeal aspirates and stools (n=3 and 5, respectively) isolated during 2005–2007 in Osaka, Japan. Influenza A virus and
norovirus were detected in the nasopharyngeal aspirates and stool samples, respectively, with other diagnostic methods. (A) RNA extracted from
clinical specimens was reverse-transcribed and random-PCR amplified to prepare template DNA for pyrosequencing. One microgram of amplified
PCR products in each sample was loaded onto a 1% agarose gel. M indicates 100-bp DNA ladder (NEB). (B) Flu-specific semi-quantitative PCR was
performed with 10-fold serial dilutions of the random-PCR products. (C) Norovirus (GII)-specific semi-quantitative PCR was performed with 10-fold
serial dilutions of the random-PCR products. Quantitative real-time RT-PCR using a norovirus-specific primer set was also performed, and the
estimated copy numbers of norovirus in samples #N1–#N5 are shown in the panel on the right. As a control, cDNA from sample #N3 without
random PCR amplification was used (left panel).
doi:10.1371/journal.pone.0004219.g001
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detected in respiratory and stool samples from children and adults.
Studies have also reported a 9-month-old patient who was co-
infected with HCoV-HKU1 and influenza C virus [29]. We showed
here that a 5-year-old child was co-infected with HCoV-HKU1 and
norovirus, although the relationship between these two viruses and/
ortherelationshipbetweenpathogenesis(enterictractillness)andco-
infection of these two viruses remains unknown. Other human
coronaviruses (OC-43, 229E, and NL63) were not detected from
these fecal samples or from the nasal samples with RT-PCR (data
not shown). Human endogenous retrovirus K (HERV-K)-derived
sequences was also detected in patient #N4, who was 3 years old
(Table 1). HERV-K is the name given to an approximately 30-
million-year-old family of endogenous retroviruses present at .50
copies per haploid human genome [30].
In addition to these human viruses, several plant virus–derived
sequences were also detected in the fecal samples (Table 1). In
particular, pepper mild mottle virus (PMMV) was found in two
specimens (#N1 and #N5) and was confirmed with RT-PCR (data
not shown). The total number of PMMV reads outnumbered the
norovirus reads in sample #N5 (Table 1). In addition, Kyuri green
mottle mosaic virus (KGMMV) was also abundantly detected in
sample #N3 (813 KGMMV-specific reads in a total 25,500 reads).
KGMMV was also detected after ultracentrifugation (data not
shown), suggesting that KGMMV viral particles were present in the
human gut. Previously,PMMVwas detected at 10
9 virions per gram
of dry weight fecal matter, and was detected in 12 (66.7%) of the 18
fecal samples collected from healthy humans [31]. This previous
publication also showed that fecal PMMV was infectious to host
plants [31]. Therefore, these plant-derived viruses may retain their
infectivity in the feces and may even be present in diarrhea. Almost
all of the detected viruses, except for the citrus tristeza virus, a
member of the Closterovirus group, belong to the Tobamovirus group
(Table 1). It is currently unknown if there is an interaction between
these plus-stranded RNA viruses and norovirus. The most
abundantly detected PMMV was also found in healthy humans
[31].Althoughthepreviouspaper[31]reportedthatthereisalackof
evidence to show that active replication of PMMV occurs in human
feces, further investigations regarding plant virus replication in the
human gut (epithelial cells) seem necessary.
As shown in Table 3, 3,039–23,955 (11.9–83.1%) reads were
estimated to be bacterial genes. Of those, more than half (54.7–
69.9%) were rRNA-derived (Table 5) and a BLAST searching
predicted the existence of commensal bacteria in the human
intestine (data not shown).
Discussion
In this study, we demonstrated the potential of the 454 parallel
sequencing platform to identify pathogenic viruses from clinical
specimens. We chose random RT-PCR for template cDNA
preparation, because of the low levels of isolated RNA from the
specimens. Flu and norovirus were detected from all three
nasopharyngeal aspirates and five stool specimens, respectively,
consistent with other diagnostic methods, including RT-PCR. In
addition to these viruses, possible pathogenic viruses, such as
WUV and HCoV-HKU1, were also detected in the nasopharyn-
geal aspirates and fecal samples, respectively, suggesting that this
system (Figure 4) is useful for novel virus identification as well as
for viral genome analysis.
In the severe acute respiratory syndrome (SARS)-CoV outbreak in
2003, it was demonstrated that a combination of stool, pooled nasal,
a n dt h r o a ts w a bs p e c i m e n sg a v et h eh i g h e s ty i e l df o rS A R S - C o V
detection by RT-PCR [32]. Thus, not only respiratory specimens but
also gastric and digestive specimens are important for the diagnosis of
emerging infectious viruses, including those with airborne transmis-
sion. In this study, we isolated whole RNA and detected viral genes
from nasal and stool samples with the 454 high-throughput
sequencing system. Flu sequences were present in 20–460 of the
21,858–30,958 reads in each nasopharyngeal aspirate (Table 1), and
thecover ratesranged from8.1–58.3% (Table 2), which wassufficient
for subtype identification in all three specimens. Furthermore, the
near-complete norovirus genome sequence was obtained in two fecal
specimens (#N2 and #N3), and more than 75% of the genome was
covered in the other two specimens (#N4 and #N5) (Table 3).
Table 1. Summary of detected viruses.
Sample Age Read Virus
#F1 3 460 Influenza A virus (H3N2)
3 Human endogenous retrovirus HCML-ARV
#F2 7 20 Influenza A virus (H1N1)
#F3 5 107 Influenza A virus (H3N2)
7 WU Polyomavirus
#N1 62
a 7 Norovirus (GII/4)
#N2 82
b 7,304 Norovirus (GII/4)
#N3 92
b 15,272 Norovirus (GII/4)
813 Kyuri green mottle mosaic virus
7 Citrus tristeza virus
3 Enterobacteria phage phiK
#N4 3
c 484 Norovirus (GII/4)
14 Human coronavirus HKU1
3 Phage phiV10
3 Human endogenous retrovirus K
#N5 44
d 762 Pepper mild mottle virus
611 Norovirus (GII/4)
17 Crucifer tobamovirus
2 Tobacco mosaic virus
aHospitalized patient.




Table 2. Summary of gene analysis in nasal samples.
Sample #F1 #F2 #F3
Total reads 30,958 (100%) 25,119 (100%) 21,858 (100%)
Eukaryotes 27,849 (90.0%) 23,760 (94.6%) 20,296 (92.9%)
Bacteria 572 (1.85%) 230 (1.23%) 272 (1.24%)
RNA viruses 506 (1.63%) 21(0.10%) 121 (0.55%)
Others 2,031 (6.56%) 1,108 (1.63%) 1,169 (5.35%)
Influenza A virus 460 (1.49%) 20 (0.08%) 103 (0.49%)
Mapping to influenza A virus genome.
Cover rate 58.30% 8.10% 25.60%
Avg. depth 3.67 0.23 0.65
The E value threshold was set to 1E+05 for taxonomy classification and 1E+40
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pyrosequencing, and found that nearly 20% of the reads had best
hits that matched currently-reported bacterial DNA sequences
[20]. These previous results, together with our findings here,
indicate that two protocols, namely direct DNA extraction for
bacteria and cell/bacterial removal by centrifugation followed by
RNA/DNA extraction for virus, could be used to comprehensively
identify pathogenic microbes in clinical samples.
Our preliminary experiments demonstrated that the detected
number of viral sequences paralleled the virus copy number in
blood samples (unpublished data), suggesting that this system is
highly quantitative. Indeed, the copy number of norovirus in the
#N1 to #N5 samples (Figure 1C), as measured by semi-
quantitative PCR, was significantly correlated with the number
of norovirus genome sequences as detected by high-throughput
sequencing (Table 1). In the case of the nasal samples, the copy
number of the influenza virus in sample #F2 was lower than those
in samples #F1 and #F3, although the endpoints of the semi-
quantitative PCR for these samples were comparable (Figure 1B).
This inconsistency could be due to differences in the sensitivities of
Figure 3. BLASTN (A) and PCR (B) analyses of WUV in Flu-positive nasopharyngeal aspirates. (A) Alignment of the WUV VP1 nucleotide
sequence. The read obtained with the GS FLX sequencer (query) was compared with that of the WUV strain CLFF (subject; NCBI accession number:
EU296475). (B) The WUV VP2 gene was detected by PCR using cDNA, which was amplified with random RT-PCR, as a template. The cDNA was diluted
10- and 100-fold and the PCR product was loaded on a 1% agarose gel. M indicates 100-bp DNA ladder.
doi:10.1371/journal.pone.0004219.g003
Table 3. Summary of gene analysis in fecal samples.
Sample #N1 #N2 #N3 #N4 #N5
Total reads 15,298 (100%) 32,335 (100%) 25,500 (100%) 18,014 (100%) 28,823 (100%)
Eukaryotes 400 (2.61%) 1,031 (22.7%) 147 (0.58%) 2,574 (14.3%) 948 (3.29%)
Bacteria 10,963 (71.7%) 14,423 (48.0%) 3,039 (11.9%) 9,180 (51.0%) 23,955 (83.1%)
RNA viruses 11 (0.07%) 8,742 (27.4%) 20,775 (81.5%) 546 (3.03%) 1,571 (5.45%)
Others 3,924 (25.7%) 8,139 (25.2%) 1,539 (6.04%) 5,714 (31.7%) 2,349 (8.15%)
Norovirus 7 (0.05%) 7,302(22.6%) 15,260 (59.8%) 484 (2.69%) 611 (2.12%)
Mapping to Norovirus genome
Cover rate 2.10% 97.00% 98.00% 77.50% 84.50%
Avg. depth 0 141.5 258.7 9.3 12.5
Reference sequence used for mapping is AY587989, Norovirus Hu/NLV/Oxford/B2S16/2002/UK.
doi:10.1371/journal.pone.0004219.t003
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to the presence of different amounts of host-derived DNA/cDNA.
Thus, quantitative analysis of host genes will be required. One
potential reason for why we obtained fewer Flu-specific reads than
norovirus reads in this study might have been the large number
(90.0–94.6% of all reads) of host-derived sequences (Figure 2 and
Table5).Thesesequenceswerepresentbecauseweperformeddirect
RNA isolation from nasopharyngeal aspirates without first eliminat-
ing the cells or tissues. Most of the detected human-derived reads
were non-coding regions, and fewer coding regions, including rRNA
andmRNAsequences,weredetectedthanexpected(Table5).These
results suggest that, although contamination by human genomic
DNA might be very low, an additional step for host gene removal is
required. Suitable subtraction step(s) using pooled human genomic
DNAs as drivers might be required to enrich in microbial genomes
[15].Alternatively,MICROBEnrich(AmbionInc.),anothermethod
for removing contaminated human-derived RNA, could be useful to
enrich microbial RNA [33]. However, the DNA virus WUV was
detected from the isolated RNA, suggesting that the WUV genome
and/or its transcripts present in infected cells were detected. Indeed,
a novel human polyomavirus (Merkel cell polyomavirus), isolated
from skin carcinoma, was detected from mRNA [17]. Taken
together, these results indicate that whole RNA isolation, including
host cells and tissues, followed by the suitable elimination of host-
derived genes could be an effective method for identifying
pathogenic viruses in clinical samples.
When several pathogens are found in a single sample, a careful
interpretation is necessary to decide which pathogen(s) is the real
cause of a specific disease. Although, the most abundant pathogen
might generally be considered to be the best candidate,
cooperative interactions between multiple pathogens cannot be
excluded as an important factor for pathogenesis. To address this
question, suitable control samples from healthy persons and/or
pair specimens, isolated after recovery, might be required.
Another possible problem with this viral genome analysis is
biased cDNA synthesis by quasi-random RT-PCR with the WTA
kit. As shown in Figure S1, a significant bias was found and its
pattern was identical in all samples. TG (CA)–rich regions were
selectively amplified with the WTA kit (Table S3), probably due to
nucleotide sequences of the quasi-random primer. Random RT-
PCR amplification using the WTA kit was at least one log higher
than that using the conventional random hexamer (data not
shown). This suggests that further improvement is required for
whole viral genome analysis, although our system is suitable for the
comprehensive detection of viral genes. In addition, the TG (CA)–
rich bias was observed within the viral genome; therefore, it seems
unlikely that the bias leads to quantitative differences of the
detected sequences with respect to the original population.
Table 4. Detected regions in HCoV-HKU1 genome.
Region (nt) Genome
3,854–4,083 Orf 1ab (Replicase)
15,956–16,147 Orf 1ab (Replicase)
24,506–24,653 Spike glycoprotein
28,082–28,310 Membrane glycoprotein - Nucleocapsid phosphoprotein
Reference sequence: HCoV HKU1 strain N15 genotype B, complete genome
(NCBI accession number: DQ415911).
doi:10.1371/journal.pone.0004219.t004
Table 5. Summary of bacterial and human-derived gene analysis.
Sample #F1 #F2 #F3
Total reads 30,958 25,119 21,858
Human 26,957 (100%) 23,029 (100%) 19,612 (100%)
rRNA 252 (0.93%) 31 (0.13%) 203 (1.04%)
coding region
a 637 (2.36%) 298 (1.29%) 449 (2.29%)
non-coding region
b 21,208 (78.7%) 18,035 (78.3%) 15,226 (77.6%)
Sample #N1 #N2 #N3 #N4 #N5
Total reads 15,298 32,335 25,500 18,014 28,823
Bacteria 10,963 (100%) 14,423 (100%) 3,039 (100%) 9,180 (100%) 23,955 (100%)
rRNA 5,994 (54.7%) 10,076 (69.9%) 1,829 (60.2%) 5,424 (59.1%) 13,772 (57.5%)
aHit reads with exon region.
bHit reads with intron and intergenic regions.
doi:10.1371/journal.pone.0004219.t005
Figure 4. Process diagram for the viral diagnosis of nasopha-
ryngeal aspirates and fecal samples.
doi:10.1371/journal.pone.0004219.g004
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and thus cannot be performed for novel or unexpected viral
infections. In thisstudy,weshowedthata diagnosticsystem based on
parallel high-throughput sequencing is useful for the direct detection
of unknown and/or small numbers of viruses, as well as for the
genetic characterization of major pathogenic viruses in clinical
specimens. We plan to share this system domestically as well as with
the Asian epidemic network (The Program of Founding Research
Centers for Emerging and Reemerging Infectious Diseases; http://
www.crnid.riken.jp), in order to enable the earlier identification of
unknown pathogens in a novel outbreak or bioterrorism.
The cost of this approach will be a key concern for its adaption by
the research community. Microbe-derived DNA/RNA enrichment
[33], with suitable elimination of host-derived genes as described
above, could reduce the required number of reads per sample. In
addition, parallel tagged sequencing [6] using sample-specific barcod-
ing adaptors with 59-nucleotide tagged PCR primers [34] would
enable the analysis of multiple samples in a single sequencing region.
If these methods were combined, it would lead to significant reduc-
tions the operating costs (i.e., $2,000 per sample) of 90% or more.
This system, which can produce .0.4 million clones per run
within a half-day, could also be very useful for the rapid
identification of important mutation(s) by direct comparison with
wild and mutant viruses, including ‘‘pandemic Flu’’ [35] and more
virulent noroviruses [36,37].
Materials and Methods
RNA isolation from clinical samples
We analyzed unlinked, anonymous samples in the Osaka
Prefectural Institute of Public Health. The samples were nasopha-
ryngeal aspirates and stools (n=3 and 5, respectively) isolated during
2005–2007 in Osaka, Japan. Seasonal influenza A virus (Flu) in
nasopharyngeal aspirates from 3- to 7-year-old children was detected
by a rapid diagnostic kit (immunochromatography) using Flu-specific
antibodies. In 2006/2007, a large-scale norovirus outbreak occurred
in Osaka, Japan, mainly infecting patients in nursing homes and
welfare facilities (53%), hospitals (27%), kindergartens (15%), and
elementary and junior high schools (5%) [26]. #N1 to #N3 samples
were collected during this outbreak. #N1 sample was derived from a
hospitalized patient and #N2 and #N3 samples were derived from
patients in a welfare facility in 2006 (October to December). #N4
sample was a kindergarten student when an outbreak occurred at the
elementary school of its elder brother and sister. In contrast to these
four cases of putative human-to-human transmission, #N5 sample
was oyster-associated. #N4 and #N5 samples were collected in May
2005 and January 2006, respectively. Diagnosis of norovirus infection
was based on RT–PCR [26]. The collected stool was suspended with
an equal amount of PBS and was centrifuged at 15,000 rpm for
10 min. The supernatants (0.25 ml) were used for RNA isolation.
This study was approved by the ethical review committees of the
RIMD, Osaka University, Osaka Prefectural Institute of Public
Health, National Institute of Infectious Diseases, and RIKEN.
Quantitative RT-PCR of norovirus
RNA extraction was performed using a Magtration-Maga-
ZorbRNA Common kit (Precision System Science) and the viral
copy number of norovirus was estimated with One-step real time RT-
PCR [26] using a One-Step Realtime PCR reagent kit (Toyobo). A
plasmid containing the target sequence was used as a control.
Random RT-PCR amplification
Total RNA was extracted from specimens with TRI-LS (Sigma-
Aldrich), and was reverse-transcribed with the Transplex whole
transcriptome amplification (WTA) kit (Sigma-Aldrich) [21] using
a quasi-random primer, according to the manufacturer’s protocol.
PCR amplification for the preparation of template DNA for
pyrosequencing was carried out by AmpliTaq Gold DNA
Polymerase LD (Applied Biosystems) [21]. Norovirus-specific
PCR was performed as described above [26], and Flu-specific
PCR was performed using the FluA M gene-specific primer set
(M30F: 59-TTCTAACCGAGGTCGAAACG-39 and M264R2:
59-ACAAAGCGTCTACGCTGCAG-39).
RT- PCR diagnosis
Viral RNA was extracted from nasopharyngeal and fecal
specimens with a QIAamp Viral RNA Mini Kit (QIAGEN), and
cDNA was synthesized using SuperScript
TM III reverse transcrip-
tase (Invitrogen) with a random hexamer, as described previously
[21]. The generated cDNA was subjected to PCR using the
Expand High Fidelity
PLUS PCR System (Roche) with primer sets
specific to viruses, such as human coronaviruses [38], WU
polyomavirus [24], and PMMV [31].
Pyrosequencing and data analysis
The amplified cDNA was used as a template for GS FLX
analysis (454 Life Sciences). A 70675 PicoTiterPlate device (gasket
for 16 regions) was divided into 2 regions for each of 8 samples.
The obtained data were then subjected to a data analysis pipeline.
Data analysis was performed on each read sequence by
computational tools, as constructed previously [20] with some
modifications. The analysis steps were: (i) remove tag sequences;
(ii) execute a BLASTN search by Hi-per BLAST (Fujitsu); (iii)
identify the scientific name for each read based on the NCBI
taxonomy database; (iv) extract viral reads and perform mapping
to reference data by SSEARCH. This analysis pipeline was
constructed by utilizing BioRuby [39], BioPerl [40], and MySQL.
After classification, particular human and bacterial reads were
further analyzed as follows. Human genome mapping was
performed by MEGABLAST search against the Human Genome,
Homo_sapiens.NCBI36.49, using a threshold of 1E-40. Bacterial
rRNA typing was performed by BLASTN search against the
comprehensive rRNA database ‘‘silva’’ release 94 [41] using a
threshold of 80% match per read.
Supporting Information
Figure S1 Cover depth of norovirus. Norovirus Hu/NLV/
Oxford/B2S16/2002/UK (NCBI accession number: AY587989)
was used as a reference sequence.
Found at: doi:10.1371/journal.pone.0004219.s001 (0.21 MB PDF)
Table S1 Summary of the best hits for each query sequences (E-
value,1E-40) in nasopharyngeal aspirates
Found at: doi:10.1371/journal.pone.0004219.s002 (0.15 MB PDF)
Table S2 Summary of the best hits for each query sequences (E-
value,1E-40) in fecal samples
Found at: doi:10.1371/journal.pone.0004219.s003 (0.20 MB PDF)
Table S3 Bias towards TG(CA)-enrichment within the detected
norovirus sequences in fecal samples
Found at: doi:10.1371/journal.pone.0004219.s004 (0.10 MB PDF)
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